Glyciphage-PG2 Tablet SR: Comprehensive Diabetes Management

Glyciphage-PG2 Tablet SR is a carefully formulated combination therapy for adults with type 2 diabetes mellitus. This once-daily tablet contains Glimepiride (2mg), Metformin (500mg), and Pioglitazone (15mg).

These three active ingredients work synergistically to control blood glucose levels, offering comprehensive management of both insulin resistance and impaired glucose tolerance:

* Glimepiride acts as a secretagogue, mimicking the body's natural incretins to increase insulin release from beta cells in the pancreas.
* Metformin inhibits hepatic gluconeogenesis, decreasing glucose production in the liver, and decreases intestinal absorption of glucose.
* Pioglitazone acts as a peroxisome proliferator-activated receptor gamma (PPARγ) agonist, increasing insulin sensitivity in peripheral tissues and facilitating glucose uptake by cells.

Glyciphage-PG2 Tablet SR is indicated for adults with type 2 diabetes mellitus who require multiple drug therapies to achieve glycemic control. It should be taken daily with or without food as prescribed by your healthcare professional.

Note: This description is for informational purposes only and does not constitute medical advice. Always consult your physician before starting any new medication, including Glyciphage-PG2 Tablet SR.